Product Program year 2024 Source: CMS Open Payments

Supera

Device Vascular

PDI 08717648226328

Open in the dashboard

General payments

$2,293,409

5,711 payments

Research payments

$2,534

1 payment

Through program year 2024, $2,293,409 in general payments and $2,534 in research payments were reported against Supera (Vascular).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2024 General $330,581 1,052
2023 General $1,556,647 2,423
2023 Research $2,534 1
2022 General $406,181 2,236

Breakdown

Who paid General payments · program years 2022–2024
  1. Abbott Laboratories $2,293,409 5,711 payments
Top recipients General payments · program year 2024
  1. Ut Md Anderson Cancer Center Teaching hospital · TX $205,993 62% · 1 payment
  2. Danielle Bajakian Vascular Surgery · New York, NY $14,708 4% · 3 payments
  3. Amr El-Sergany Vascular Surgery · Aiea, HI $14,400 4% · 1 payment
  4. Damian Grovas Abad Interventional Cardiology · San Juan, PR $8,994 3% · 38 payments
  5. Johnathon Rollo Vascular Surgery · Los Angeles, CA $5,305 2% · 27 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Vascular Surgery Surgery $48,154 39% · 109 practitioners
  2. Interventional Cardiology Internal Medicine $31,138 25% · 129 practitioners
  3. Cardiovascular Disease Internal Medicine $16,215 13% · 71 practitioners
  4. Podiatrist $3,367 3% · 26 practitioners
  5. Vascular & Interventional Radiology Radiology $3,317 3% · 38 practitioners

The top 5 of 53 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. Texas $211,724 64% · 83 recipients
  2. New York $26,760 8% · 65 recipients
  3. Hawaii $14,400 4% · 1 recipient
  4. California $13,923 4% · 63 recipients
  5. Florida $10,004 3% · 49 recipients

The top 5 of 43 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

5,711 general · 1 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record